70
Participants
Start Date
May 25, 2021
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2027
Talazoparib Oral Capsule
\- Patients will receive Talazoparib 1 mg orally once daily continuously, with or without food. Laboratory values will be monitored every 4 weeks until progression or unacceptable toxicity. Dose modifications should be made based on the observed toxicity
RECRUITING
Seoul National University Hospital, Seoul
Seoul National University Hospital
OTHER